NPSP

NPS Pharmaceuticals, Inc. Competitors

$14.53
*  
0.42
  negative  
2.98%
Get NPSP Alerts
*Delayed - data as of May 21, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

NPS Pharmaceuticals, Inc.
CompanyName
Symbol : Market
LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Vical Incorporated
VICL: NASDAQ-GS
$ 3.63 0.02   395,272 $ 3.70
$ 3.60
$ 4.74
$ 2.61
NE 313,080,240
TrovaGene, Inc.
TROVW: NASDAQ-CM
$ 3.40 unch n/a
n/a
$ 4.44
$ .2001
NE 3,910,000
TrovaGene, Inc.
TROVU: NASDAQ-CM
$ 16.75 unch n/a
n/a
$ 21.30
$ 4.56
NE 19,262,500
TrovaGene, Inc.
TROV: NASDAQ-CM
$ 6.84 -0.01   65,347 $ 6.92
$ 6.53
$ 8.96
$ 2.09
NE 106,129,440
Techne Corporation
TECH: NASDAQ-GS
$ 68 0.22   120,119 $ 68.53
$ 67.52
$ 76.02
$ 62.55
22.44 2,505,256,000
StemCells, Inc.
STEM: NASDAQ-CM
$ 1.86 -0.04   387,369 $ 1.93
$ 1.86
$ 2.67
$ .59
NE 69,638,400
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 7.84 -0.02   682,203 $ 7.93
$ 7.62
$ 11.24
$ 4.04
NE 418,287,520
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 35.73 -0.02   450,242 $ 36.20
$ 35.50
$ 39
$ 19.03
NE 4,303,249,740
Repros Therapeutics Inc.
RPRXZ: NASDAQ-CM
$ 15.729 unch n/a
n/a
$ 37.68
$ 8
NE 13,464,024
Repros Therapeutics Inc.
RPRXW: NASDAQ-CM
$ 14.72 unch n/a
n/a
$ 39.99
$ 11.23
NE 12,909,440
Repros Therapeutics Inc.
RPRX: NASDAQ-CM
$ 15.62 -0.12   673,167 $ 15.83
$ 15.14
$ 20.78
$ 7.30
NE 267,351,920
Repligen Corporation
RGEN: NASDAQ-GS
$ 8.61 -0.09   262,062 $ 8.77
$ 8.53
$ 9.65
$ 3.72
17.94 267,874,320
Qiagen N.V.
QGEN: NASDAQ-GS
$ 18.58 0.07   607,017 $ 18.72
$ 18.53
$ 22.20
$ 15.66
37.16 4,393,928,460
Pluristem Therapeutics, Inc.
PSTI: NASDAQ-CM
$ 3.06 0.06   177,570 $ 3.068
$ 2.98
$ 5
$ 2.26
NE 179,435,340
Protalix BioTherapeutics, Inc.
PLX: AMEX
$ 5.21 0.01   104,248 $ 5.25
$ 5.18
$ 6.80
$ 4.71
NE 487,150,630
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 8.37 0.16   1,941,739 $ 8.37
$ 8.22
$ 8.43
$ 6.18
5.44 1,171,239,210
OXiGENE, Inc.
OXGN: NASDAQ-CM
$ 3.23 -0.02   9,919 $ 3.35
$ 3.22
$ 11.7647
$ 3.101
NE 6,640,880
Osiris Therapeutics, Inc.
OSIR: NASDAQ-GM
$ 10.85 0.15   75,195 $ 11.01
$ 10.54
$ 14.46
$ 5.51
NE 356,693,750
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS
$ 92.91 -1.43   1,329,967 $ 95.50
$ 92.71
$ 101.569
$ 41.26
NE 6,690,077,460
Novavax, Inc.
NVAX: NASDAQ-GS
$ 1.96 -0.02   710,234 $ 2.02
$ 1.95
$ 2.77
$ 1.14
NE 289,964,360
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GM
$ 14.53 0.42   2,153,953 $ 14.89
$ 13.79
$ 14.77
$ 6.62
NE 1,262,773,240
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 12.06 0.05   430,513 $ 12.12
$ 11.71
$ 12.85
$ 6.25
NE 802,098,540
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 13.08 0.21   408,096 $ 13.10
$ 12.77
$ 17.09
$ 10.05
NE 676,837,680
Medgenics, Inc.
MDGN: AMEX
$ 4.15 -0.03   4,530 $ 4.23
$ 4.0825
$ 16.43
$ 3.66
NE 76,696,150
Lpath, Inc.
LPTN: NASDAQ-CM
$ 4.90 -0.05   30,442 $ 4.99
$ 4.88
$ 7.01
$ 4.13
NE 64,194,900